Table 1.
Clinical characteristics of the patients
| MIS-C n = 32 | |
|---|---|
| Age at onset (years) | 8.25 ± 4 |
| Male | 21 (65.6) |
| Comorbidity | 3 (9.4) |
| Associated CHD | 1 bicuspid aortic valve |
| positive NF SARS-CoV-2 swab | 4 (12.5) |
| positive SARS-CoV-2 IgG title | 27 (84.4) |
| Clinical manifestations | |
| Fever | 32 (100) |
| GI | 27 (84.4) |
| Muco-cutaneous | 22 (68.8) |
| Neurological | 7 (22) |
| Hypotension | 9 (28.1) |
| Sinus Bradicardia | 9 (28.1) |
| KD-like | 13 (40.6) |
| ICU admission | 5 (15.6) |
| Laboratory | |
| TnI ≤ 34 ng/L TnI >34 ng/L |
12 (37.5) 20 (62.5) |
| BNP (pg/mL) | 612 ± 859 |
| CRP (mg/L) | 162 ± 91.4 |
| PCT (ng/mL) | 12.3 ± 86 |
| ESR (mm/h) | 54.5 ± 36.5 |
| Ferritin (mcg/L) | 922 ± 837 |
| D-dimer (mcg/mL) | 2069.4 ± 2484 |
| LDH (U/L) | 385 ± 255 |
| Treatment | |
| IV steroids | 32 (100) |
| IGIV | 32 (100) |
| Aspirin | 31 (97) |
| Anakinra | 3 (9,4) |
| Other | 4 (12,5) |
Values are numbers (%) or mean ± standard deviation.
CHD, congenital heart disease, BNP, brain natriuretic peptide; CRP, C-reactive protein; ERS, erythrocyte sedimentation rate); GI, gastrointestinal symptoms; ICU, intensive care unit; IV, intravenous; IVIG, intravenous immunoglobulins; KD, Kawasaki disease; LDH, lactic dehydrogenase; PCT, procalcitonin; NP swab, naso-pharingeal swab; TnI, troponin I; WBC, white blood count.